Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 148

In this episode I am looking forward to exploring more about alternate interpretations of Quantum Mechanics. In previous episodes exploring consciousness, I’ve encountered several people who believe that Quantum Mechanics is at the root of consciousness. My current thinking is that it replaces one mystery with another one without really providing an explanation for consciousness. We are still stuck with the options of consciousness being a pre-existing property of the universe or some aspect of it, vs. it being an emergent feature of a processing network. Either way, quantum mechanics is an often misunderstood brilliant theory at the root of physics. It tells us that basic particles don’t exist at a specific position and momentum—they are, however, represented very accurately as a smooth wavefunction that can be used to calculate the distribution of a set of measurements on identical particles. The process of observation seems to cause the wavefunction to randomly collapse to a localized spot. Nobody knows for certain what causes this collapse. This is known as the measurement problem. The many worlds theorem says the wavefunction doesn’t collapse. It claims that the wavefunction describes all the possible universes that exist and the process of measurement just tells us which universe we are living in.

My guest is a leading proponent of transactional quantum mechanics.

Dr. Ruth E. Kastner earned her M.S. in Physics and Ph.D. in History and Philosophy of Science from the University of Maryland. Since that time, she has taught widely and conducted research in Foundations of Physics, particularly in interpretations of quantum theory. She was one of three winners of the 2021 Alumni Research Award at the University of Maryland, College Park (https://tinyurl.com/2t56yrp2). She is the author of 3 books: The Transactional Interpretation of Quantum Theory: The Reality of Possibility (Cambridge University Press, 2012; 2nd edition just published, 2022), Understanding Our Unseen Reality: Solving Quantum Riddles (Imperial College Press, 2015); and Adventures In Quantumland: Exploring Our Unseen Reality (World Scientific, 2019). She has presented talks and interviews throughout the world and in video recordings on the interpretational challenges of quantum theory, and has a blog at transactionalinterpretation.org. She is also a dedicated yoga practitioner and received her 200-Hour Yoga Alliance Instructor Certification in February, 2020.

Visit my website at www.therationalview.ca.

Join the Facebook conversation @TheRationalView.

Twitter @AlScottRational.

Continue reading “Dr. Ruth Kastner and the transactional interpretation of quantum mechanics” | >

Theme: Lifelong Brain Development.

Abstract: The human brain sets us apart as a species, with its size being one of its most striking features. Brain size is largely determined during development as vast numbers of neurons and supportive glia are generated. In an effort to better understand the events that determine the human brain’s cellular makeup, and its size, we use a human model system in a dish, called cerebral organoids. These 3D tissues are generated from pluripotent stem cells through neural differentiation and a supportive 3D microenvironment to generate organoids with the same tissue architecture as the early human fetal brain. Such organoids are allowing us to tackle questions previously impossible with more traditional approaches. Indeed, our recent findings provide insight into regulation of brain size and neuron number across ape species, identifying key stages of early neural stem cell expansion that set up a larger starting cell number to enable the production of increased numbers of neurons. We are also investigating the role of extrinsic regulators in determining numbers and types of neurons produced in the human cerebral cortex. Overall, our findings are pointing to key, human-specific aspects of brain development and function, that have important implications for neurological disease.

About this series: The Cambridge Neuroscience Interdisciplinary Seminar Series provides a forum for neuroscientists across Cambridge and beyond to discuss contemporary and interdisciplinary research topics and issues.

The seminars are open to both members of the University, external academics and members of the public. We have tried to reflect the diversity of people’s interests at the University with our programme, and the breadth of the research taking place in Cambridge. Registration and more details are available here: http://talks.cam.ac.uk/show/index/125062

For more information on Cambridge Neuroscience, please see www.neuroscience.cam.ac.uk or follow us on Twitter @CamNeuro

Read more | >

UCLA Broad Stem Cell Research Center member Ranmal Samarasinghe, MD, PhD presents his work using brain organoids to create better models of neurological disorders. An Assistant Professor in UCLA’s Neurology department, Dr. Samarasinghe splits his time between the clinic, seeing patients who have neurological conditions like epilepsy and autism, and in the lab working to create more detailed disease models using brain organoids. In this video, Dr. Samarasinghe discusses how brain organoids are becoming more sophisticated in their ability to replicate irregular brain wave patterns seen in conditions like Rett syndrome, an epilepsy primarily associated with infants. Ultimately, he hopes these stem cell-based models can be used to screen new drugs and discover new treatments for diseases like epilepsy.

Learn more about Dr. Samarasinghe’s work here:
https://stemcell.ucla.edu/member/sama… the full “The Power of Regenerative Medicine: Future Treatments for Brain Disease” webinar: • The Power of Regenerative Medicine: F…

Watch the full \.

Read more | >

While these are two separate chronic conditions, they are linked as about one in every three adults with type 2 diabetes also has chronic kidney disease.

Additionally, both conditions are associated with an increased risk for cardiovascular complications such as stroke and heart attack.

Read more | >

The BCI is rapidly evolving, but the real challenge has always been the long-term usability of devices implanted in the brain. Because of this, it is exciting to see the early success stories of Neuralink with the three patients who have received chip implants so far. They have all achieved results beyond expectations without any risks, which has made Elon Musk even more confident and ambitious with his implanted chip. He has decided to upgrade the chip to a higher level to support more people with disabilities. At the same time, Musk has shared updates on the condition of the three Neuralink-implanted patients. This year, the number of implant recipients is expected to increase significantly. So, is this a major turning point for people to trust Neuralink? Explore the latest updates now, Welcome to Tesla Car World!

Full NEURALINK Human Trials! Elon Musk Reveals NEW Updates On Three Patient Shocking In 2025! You may not believe it, but from the perspective of many people, Neuralink is one of Elon Musk’s most controversial and ridiculous companies. They argue that Musk should focus on Tesla and SpaceX instead of a less widely accepted field like BCI. Concerns about the dangers of implanting chips in the brain, especially given how new this technology is, remain a hot topic of discussion. Some even fear that brain data could be misused or compromised if Neuralink were hacked. However, despite these concerns, it is undeniable that for the three implanted patients, Neuralink means more than ever. They seem to be living a second life, in fact, Neuralink makes them feel as if they have been reborn.

Full NEURALINK Human Trials! Elon Musk Reveals NEW Updates On Three Patient Shocking In 2025! Imagine losing the ability to move, communicate, or control your own body. Then, one day, something allows you to think and control a computer cursor, communicate with the world through your thoughts, and do things you had once given up hope on. For the three patients who have experienced Neuralink, this is not just an ordinary chip, it is an opportunity, a hope, a real-life miracle.
===
#888999evs #teslacarworld #teslacar #888999 #teslaneuralink #neuralink.
subcribe: https://bit.ly/3i7gILj

Read more | >

Health, vitality and longevity through bioengineering — kevin caldwell — CEO, ossium health.

Kevin Caldwell is CEO, Co-Founder & President of Ossium Health (https://ossiumhealth.com/), a commercial stage bioengineering company that leverages its proprietary organ donor bone marrow banking platform to develop stem cell therapies for patients with life-threatening hematologic conditions, organ transplant rejection, and musculoskeletal defects.

Mr. Caldwell built Ossium from a small startup into the clinical stage bioengineering company it is today, setting the company’s mission to improve human health through bioengineering and designed its platform-based model for cellular therapeutics development. He has led the company’s successful pursuit, negotiation, and execution of more than 50 business relationships, including 5 successful fundraisings and dozens of supply partnerships, clinical partnerships, and commercial contracts with biopharmaceutical companies.

After seven years of strategic engagement and networking, Mr. Caldwell drove the team to successfully secure a transformative federal contract with BARDA (Biomedical Advanced Research and Development Authority) that validates Ossium’s innovative approach. This milestone represents the culmination of persistent relationship-building, targeted proposals, and unwavering commitment to addressing national biomedical challenges through cutting-edge technology and collaborative partnerships.

Prior to founding Ossium, Mr. Caldwell served as an Engagement Manager at McKinsey’s San Francisco office where he advised clients in the biotechnology and healthcare sectors. His projects ranged from due diligence of acquisition targets in the biotech startup ecosystem to restructuring distressed biopharma companies. Mr. Caldwell led more than 20 engagements with more than a dozen clients, leading teams that advised clients on revenue growth, go to market strategy, and organizational restructuring.

Continue reading “Kevin Caldwell — CEO, Ossium Health — Health, Vitality And Longevity Through Bioengineering” | >

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links/Affiliates:
Blood testing (where I get the majority of my labs): https://www.ultalabtests.com/partners/michaellustgarten.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

Clearly Filtered Water Filter: https://get.aspr.app/SHoPY

Epigenetic, Telomere Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/

Continue reading “19y Younger Biological Age (Blood Test #1 In 2025)” | >

Chemistry researchers at Case Western Reserve University have identified specific markers that could pave the way for new blood tests to detect diseases.

Almost every disease involves some degree of inflammation, yet standard blood tests cannot precisely identify which organs or tissues are affected.

Now, researchers at Case Western Reserve University have developed an antibody-based method to detect inflammation, which could pave the way for blood tests that identify disease-specific biomarkers. This advancement has potential applications in diagnosing conditions such as heart disease, Alzheimer’s.

Read more | >